CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Bernstein Adjusts PT on Regeneron Pharmaceuticals to $756 From $753, Maintains Market Perform Rating

Neutral
AI Analysis

Summary

Bernstein adjusted its price target on Regeneron Pharmaceuticals from $753 to $756 while maintaining a Market Perform rating.

Importance:2/10
Sentiment:
0.00
price_target_adjustmentanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on August 14, 2026 10:11 AM

Read Original